Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Moderate to severe Rheumatoid arthritis (RA) according to American College of Rheumatology (ACR) criteria
Methotrexate failure
Naive to RA biologics
≤5 years duration of disease
Disease Activity Score-28 C-reactive protein (DAS28 CRP) ≥ 3.2
Willingness to self-inject subcutaneous (SC) drug
You may not be if
Previous or current medical conditions that are warnings against the use of tumor necrosis factor (TNF)-blocking agents
History of active or chronic hepatitis
Cancer in the last 5 years
History of severe chronic or recurrent bacterial or viral infections
Risk of tuberculosis
Current symptoms of severe, progressive, or uncontrolled renal, hepatic, hematologic, Gastro-intestinal, pulmonary, cardiac, neurologic, or cerebral disease
Clareo Health | Abatacept Versus Adalimumab Head-to-Head
